专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2012094386A1 GENERATION OF ANTIBODIES TO TUMOR ANTIGENS AND GENERATION OF TUMOR SPECIFIC COMPLEMENT DEPENDENT CYTOTOXICITY BY ADMINISTRATION OF ONCOLYTIC VACCINIA VIRUS 审中-公开
标题翻译：抗肿瘤抗生素的产生和肿瘤特异性补体的产生依赖于毒理性疫苗病毒的依赖性细胞毒性
公开(公告)号：WO2012094386A1
公开(公告)日：2012-07-12
申请号：PCT/US2012/020173
申请日：2012-01-04
申请人： JENNEREX INC. , KIRN, David , BELL, John , BREITBACH, Caroline , MOON, Anne , HWANG, Tae-Ho , LEE, Yu Kyoung , KIM, Mi-kyung , INSTITUTE FOR RESEARCH & INDUSTRY COOPERATION, PUSAN NATIONAL UNIVERSITY
发明人： KIRN, David , BELL, John , BREITBACH, Caroline , MOON, Anne , HWANG, Tae-Ho , LEE, Yu Kyoung , KIM, Mi-kyung
IPC分类号： A61K39/12
CPC分类号： A61K39/285 , A61K35/26 , A61K35/76 , A61K35/761 , A61K35/763 , A61K35/768 , A61K39/0011 , A61K39/12 , A61K39/125 , A61K39/145 , A61K39/165 , A61K39/17 , A61K39/205 , A61K39/235 , A61K39/245 , A61K39/395 , A61K45/06 , A61K2039/505 , A61K2039/507 , A61K2039/55522 , C07K16/18 , C07K16/30 , C07K2317/14 , C07K2317/734 , C12N7/00 , C12N2710/10034 , C12N2710/16632 , C12N2710/16634 , C12N2710/24034 , C12N2710/24132 , C12N2720/12232 , C12N2750/14034 , C12N2760/16034 , C12N2760/18134 , C12N2760/18434 , C12N2760/18734 , C12N2760/20034 , C12N2760/20232 , C12N2770/32034 , C12N2770/32334 , C12N2770/36034 , G01N33/574
摘要： The present invention relates to methods and compositions for use in inducing tumor-specific antibody mediated complement-dependent cytotoxic response in an animal having a tumor comprising administering to said animal a composition comprising a replication competent oncolytic virus wherein administration of the composition induces in the animal production of antibodies that mediate a CDC response specific to said tumor.
摘要翻译：本发明涉及用于在具有肿瘤的动物中诱导肿瘤特异性抗体介导的补体依赖性细胞毒性应答的方法和组合物，包括向所述动物施用包含复制能力的溶瘤病毒的组合物，其中组合物在动物中的诱导产生介导对所述肿瘤特异性的CDC反应的抗体。

2. 发明申请

WO2011122815A3 NOVEL QUINOXALINE DERIVATIVES 审中-公开
标题翻译：新型喹啉衍生物
公开(公告)号：WO2011122815A3
公开(公告)日：2012-03-08
申请号：PCT/KR2011002115
申请日：2011-03-28
申请人： DONG A PHARM CO LTD , MOON HO-SANG , YANG JAE-SUNG , KIM MI-KYUNG , KIM JIN-KWAN , LEE JAE-YOUNG , KANG SO-MI , KIM HA-DONG , SHIN CHANG-YELL , CHEONG YE-HWANG , YANG EUN-KYOUNG , CHOI SONG-HYEN , PARK YOUNG-SOO , KIM EUN-JUNG , CHAE YU-NA , CHO EUN-JUNG , SON MOON-HO , KIM SOON-HOE
发明人： MOON HO-SANG , YANG JAE-SUNG , KIM MI-KYUNG , KIM JIN-KWAN , LEE JAE-YOUNG , KANG SO-MI , KIM HA-DONG , SHIN CHANG-YELL , CHEONG YE-HWANG , YANG EUN-KYOUNG , CHOI SONG-HYEN , PARK YOUNG-SOO , KIM EUN-JUNG , CHAE YU-NA , CHO EUN-JUNG , SON MOON-HO , KIM SOON-HOE
IPC分类号： C07D417/14 , A61K31/498 , A61P3/04 , A61P3/10 , C07D403/12
CPC分类号： C07D417/14 , C07D403/12
摘要： This invention relates to a novel compound represented by the following Chemical Formula 1, a process for preparing it, and its pharmaceutically approved salt comprising it as an active ingredient. The compound of this invention is GLP 1 receptor regulating low molecular weight compound useful for treatment of metabolic diseases such as diabetes and obesity by regulating the function of glucagon like peptide 1 receptor (GLP 1 receptor) for the disease or disorder carried by GLP 1 since it has the effects on a drop of blood sugar and an improvement of insulin resistance.
摘要翻译：本发明涉及由以下化学式1表示的新化合物，其制备方法及其药学上可接受的盐，其作为活性成分。本发明的化合物是通过调节GLP1携带的疾病或病症的胰高血糖素样肽1受体（GLP 1受体）的功能，用于治疗诸如糖尿病和肥胖症等代谢疾病的GLP 1受体调节低分子化合物，因为它对一滴血糖和胰岛素抵抗的改善有影响。

3. 发明申请

WO2009136672A1 ROTATING ANGLE DETECTION DEVICE USED CAPACITIVE CHANGE AND METHOD THEREOF 审中-公开
标题翻译：旋转角度检测装置使用电容变化及其方法
公开(公告)号：WO2009136672A1
公开(公告)日：2009-11-12
申请号：PCT/KR2008/002596
申请日：2008-05-08
申请人： KIM, Mi Kyung , LEE, Rae Duk , KIM, Dong Seok
发明人： KIM, Mi Kyung , LEE, Rae Duk , KIM, Dong Seok
IPC分类号： G01P3/483 , G01B7/30 , G01J1/02
CPC分类号： G01D5/2412
摘要： This invention can increase the resolving power of the rotating angle using the rate of capacity change between two objects. The objective is to provide a rotating angle detecting device using capacitive change that is small in size and costs low to manufacture. The method to reach the above objective is a rotating angle detection device with a stator with two fixed conductor plates; and a rotator with a rotating conductor plate that rotates relatively to the above stator, with every rotation overlapping and passing the above fixed conductor plates repeatedly with different area change.
摘要翻译：本发明可以使用两个物体之间的容量变化率来提高旋转角度的分辨率。目的是提供使用电容变化的旋转角度检测装置，其尺寸小，制造成本低。达到上述目的的方法是具有带有两个固定导体板的定子的旋转角度检测装置; 以及具有相对于上述定子旋转的旋转导体板的转子，每次旋转重叠并且以不同的面积变化反复地通过上述固定导体板。

4. 发明申请

WO2008108602A1 NOVEL PHENYLPROPIONIC ACID DERIVATIVES AS PEROXISOME PROLIFERATOR-ACTIVATED GAMMA RECEPTOR MODULATORS, METHOD OF THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME 审中-公开
标题翻译：新戊二酸衍生物作为过氧化物促进剂活化的游离体受体调节剂，其方法和包含其的药物组合物
公开(公告)号：WO2008108602A1
公开(公告)日：2008-09-12
申请号：PCT/KR2008/001322
申请日：2008-03-07
申请人： DONG-A PHARM. CO., LTD. , YUHAN CO., LTD. , MOON, Ho-Sang , YOO, Moo-Hi , KIM, Soon-Hoe , LIM, Joong-In , SON, Moon-Ho , KIM, Mi-Kyung , SHIN, Chang-Yell , KIM, Jin-Kwan , PARK, Sang-Kuk , CHAE, Yu-Na , SHIM, Hyun-Joo , JEON, Sun-Ho , KIM, Hae-Sun , WIE, Gil-Tae , KIM, Dong-Hwan , LEE, Byung-Kyu , PARK, Chan-Sun , AHN, Byung-Nak , KIM, Eunkyung , BAE, Myung-Ho , SHIN, Young-Ah , HUR, Youn , LEE, Chun-Ho , CHOI, Hyun-Ho , KIM, Bongtae , CHONG, Wonee
发明人： MOON, Ho-Sang , YOO, Moo-Hi , KIM, Soon-Hoe , LIM, Joong-In , SON, Moon-Ho , KIM, Mi-Kyung , SHIN, Chang-Yell , KIM, Jin-Kwan , PARK, Sang-Kuk , CHAE, Yu-Na , SHIM, Hyun-Joo , JEON, Sun-Ho , KIM, Hae-Sun , WIE, Gil-Tae , KIM, Dong-Hwan , LEE, Byung-Kyu , PARK, Chan-Sun , AHN, Byung-Nak , KIM, Eunkyung , BAE, Myung-Ho , SHIN, Young-Ah , HUR, Youn , LEE, Chun-Ho , CHOI, Hyun-Ho , KIM, Bongtae , CHONG, Wonee
IPC分类号： C07D333/16
CPC分类号： C07D333/16 , C07D409/10 , C07D409/12 , C07D413/10 , C07D417/10
摘要： The present invention provides a novel phenylpropionic acid derivative and a PPAR-γ modulator comprising the same as an active ingredient. The phenylpropionic acid derivative of the present invention has modulatory action on function of PPAR-γ and then exhibits hypoglycemic, hypolipidemic and insulin resistance-reducing effects on PPAR-mediated diseases or disorders. Therefore, the present invention is prophylactically or therapeutically effective for diabetes and metabolic diseases.
摘要翻译：本发明提供新的苯丙酸衍生物和PPAR- 包含其作为活性成分的调节剂。本发明的苯丙酸衍生物对PPAR-α的功能具有调节作用然后对PPAR介导的疾病或病症表现出降血糖，降血脂和胰岛素抵抗减少作用。因此，本发明对于糖尿病和代谢疾病具有预防性或治疗上的有效性。

5. 发明申请

WO2008023966A1 NOVEL USE OF PANDURATIN A OR DERIVATIVES THEREOF 审中-公开
标题翻译：潘德拉汀A或其衍生物的新用途
公开(公告)号：WO2008023966A1
公开(公告)日：2008-02-28
申请号：PCT/KR2007/004109
申请日：2007-08-27
申请人： Industry-Academic Cooperation Foundation, Yonsei University , HWANG, Jae-Kwan , KIM, Mi-Kyung , SONG, Min-Soo , SHIM, Jae-Seok , YOON, Ji-Hoon
发明人： HWANG, Jae-Kwan , KIM, Mi-Kyung , SONG, Min-Soo , SHIM, Jae-Seok , YOON, Ji-Hoon
IPC分类号： A61K31/122
CPC分类号： A61K31/122
摘要： The present invention relates to the novel use of a panduratin A compound, derivative thereof or an extract of Kaempferia pandurata. More particularly, it relates to the use for the antibacterial activities and acne treatment of a panduratin A compound represented by Formula 1, a panduratin A derivative represented by Formula 2 or an extract of Kaempferia pandurata. The above panduratin A compound, derivative thereof or extract of Kaempferia pandurata has excellent antibacterial activity of inhibiting the growth of bacteria selected from the group consisting of Propionibacterium acnes, Staphylococcus epidermidis, Micrococcus luteus, Staphylococcus aureus, Staphylococcus warneri, Staphylococcus haemolyticus, Staphylococcus xylosus, Staphylococcus hominis and Staphylococcus saprophyticus. Accordingly, the inventive compounds or extract may be very useful as an antibacterial composition or a composition for treating acne against the above bacteria.
摘要翻译：本发明涉及一种潘多蛋白A化合物，其衍生物或山茶皮提取物的新用途。更具体地说，涉及用式1表示的潘多蛋白A化合物，式2表示的潘多汀A衍生物或白头翁提取物的抗菌活性和痤疮治疗用途。上述潘多蛋白A化合物，其衍生物或山茶皮提取物具有优异的抗菌活性，其抑制选自以下的细菌的生长：丙酸杆菌属，表皮葡萄球菌，藤黄微球菌，金黄色葡萄球菌，葡萄球菌，溶血葡萄球菌，葡萄球菌，人类葡萄球菌和腐生葡萄球菌。因此，本发明化合物或提取物可以作为抗菌组合物或用于治疗针对上述细菌的痤疮的组合物非常有用。

6. 发明申请

WO2011118976A2 PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND THE METHOD FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE USING THE SAME 审中-公开
标题翻译：用于预防或治疗非酒精性脂肪肝疾病的药物组合物及使用该方法预防或治疗非酒精性脂肪肝病
公开(公告)号：WO2011118976A2
公开(公告)日：2011-09-29
申请号：PCT/KR2011/001988
申请日：2011-03-23
申请人： DONG-A PHARM. CO., LTD. , AN, Gook-Jun , YANG, Eun-Kyoung , CHO, Eun-Jung , CHAE, Yu-Na , CHOI, Song-Hyen , KIM, Ha-Dong , SHIN, Chang-Yell , KIM, Mi-Kyung , KWAK, Woo-Young , KIM, Heung-Jae , SON, Moon-Ho , KIM, Soon-Hoe
发明人： AN, Gook-Jun , YANG, Eun-Kyoung , CHO, Eun-Jung , CHAE, Yu-Na , CHOI, Song-Hyen , KIM, Ha-Dong , SHIN, Chang-Yell , KIM, Mi-Kyung , KWAK, Woo-Young , KIM, Heung-Jae , SON, Moon-Ho , KIM, Soon-Hoe
IPC分类号： A61K31/496 , A61K31/401 , A61P1/16 , A61P1/00
CPC分类号： A61K31/495 , A61K31/4985
摘要： The present invention provides a pharmaceutical composition for the prevention and treatment of a non-alcoholic fatty liver disease (NAFLD), containing an active ingredient selected from the group consisting of Compound 1 represented by formula 1, sitagliptin, vildagliptin, linagliptin or a pharmaceutically acceptable salt thereof. Further, the present invention provides a method for the prevention or treatment of a non-alcoholic fatty liver disease, including administering an effective amount of an active ingredient selected from the group consisting of Compound 1 represented by formula 1, sitagliptin, vildagliptin, linagliptin or a pharmaceutically acceptable salt thereof to a mammal including a human in need thereof. Further, the present invention provides use of Compound 1 represented by formula 1, sitagliptin, vildagliptin, linagliptin or a pharmaceutically acceptable salt thereof, for manufacturing a pharmaceutical composition for the prevention or treatment of a non-alcoholic fatty liver disease.
摘要翻译：本发明提供了一种用于预防和治疗非酒精性脂肪肝疾病（NAFLD）的药物组合物，其含有选自由式1表示的化合物1，西格列汀，维格列汀，利格列汀或其药学上可接受的组的盐。此外，本发明提供了一种预防或治疗非酒精性脂肪性肝病的方法，包括给予有效量的选自由式1表示的化合物1，西格列汀，维格列汀，利格列汀或其药学上可接受的盐包括需要其的人的哺乳动物。此外，本发明提供了用于制备用于预防或治疗非酒精性脂肪肝疾病的药物组合物的式1化合物1，西他列汀，维格列汀，利格列汀或其药学上可接受的盐的用途。

7. 发明申请

WO2009142459A2 MICROALGAE WITH HIGH-EFFICIENT ABILITY TO REMOVE CARBON DIOXIDE AND USE THEREOF 审中-公开
标题翻译：具有高效去除二氧化碳的微量元素及其用途
公开(公告)号：WO2009142459A2
公开(公告)日：2009-11-26
申请号：PCT/KR2009002724
申请日：2009-05-22
申请人： ECOPHYCO TECH LTD , KIM MI-KYUNG , HAN MYUNG-SOO , JIN EON-SEON , LEE CHOUL-GYUN
发明人： KIM MI-KYUNG , HAN MYUNG-SOO , JIN EON-SEON , LEE CHOUL-GYUN
IPC分类号： C12N1/12
CPC分类号： C12N1/12 , B01D53/62 , B01D53/84 , B01D2251/95 , B01D2257/504 , C12R1/89 , Y02A50/2358 , Y02C10/02 , Y02C10/04 , Y02P20/59 , Y02W10/37
摘要： The present invention relates to microalgae with high-efficient ability to remove carbon dioxide, and use thereof. More specifically, the invention relates to Scenedesmus producto-capitatus microalgae with a high carbon dioxide fixation rate, and use thereof. The microalgae according to the present invention has a high carbon dioxide fixation rate and excellent resistance to carbon dioxide, sulfur oxides (SOx), and nitrogen oxides (NOx), and also has abundant biomass, so the microalgae can be used in microalgae preparations for removing carbon dioxide.
摘要翻译：本发明涉及具有高效除去二氧化碳能力的微藻及其用途。更具体地说，本发明涉及具有高二氧化碳固定速率的扇贝藻属（Scenedesmus producti-capitatus microalgae）及其用途。根据本发明的微藻具有高的二氧化碳固定速率和优异的耐二氧化碳，硫氧化物（SOx）和氮氧化物（NOx）的能力，并且还具有丰富的生物质，因此微藻可用于微藻制剂去除二氧化碳。

8. 发明申请

WO2007142404A1 CAMERA DEVICE WITH VACUUM TUBE 审中-公开
标题翻译：具有真空管的摄像机
公开(公告)号：WO2007142404A1
公开(公告)日：2007-12-13
申请号：PCT/KR2007/001834
申请日：2007-04-16
申请人： YEOM, Dong-Yeop , KIM, Mi-Kyung
发明人： YEOM, Dong-Yeop , KIM, Mi-Kyung
IPC分类号： G03B17/08
CPC分类号： G03B17/08 , G08B13/19619
摘要： The present invention relates to a camera device with a vacuum tube; and, more particularly, to a camera device using a vacuum tube capable of being used for a fixed outdoor surveillance camera and a camera module supported by a supporting member inside of the vacuum tube. The camera device includes a vacuum tube, a camera module installed inside of the vacuum tube, a supporting member for supporting the camera module on the vacuum tube, a pin installed at a lower part of the vacuum tube, which is connected with a socket for electrically connecting
摘要翻译：本发明涉及具有真空管的相机装置; 更具体地，涉及一种使用能够用于固定室外监视摄像机的真空管和由真空管内的支撑构件支撑的照相机模块的照相机装置。相机装置包括真空管，安装在真空管内部的相机模块，用于将相机模块支撑在真空管上的支撑部件，安装在真空管下部的销，其与插座连接，电连接

9. 发明申请

WO2012094386A9 GENERATION OF ANTIBODIES TO TUMOR ANTIGENS AND GENERATION OF TUMOR SPECIFIC COMPLEMENT DEPENDENT CYTOTOXICITY BY ADMINISTRATION OF ONCOLYTIC VACCINIA VIRUS 审中-公开
标题翻译：抗肿瘤抗生素的产生和肿瘤特异性补体的产生依赖于毒蕈碱疫苗病毒的依赖性细胞毒性
公开(公告)号：WO2012094386A9
公开(公告)日：2013-08-15
申请号：PCT/US2012020173
申请日：2012-01-04
申请人： JENNEREX INC , KIRN DAVID , BELL JOHN , BREITBACH CAROLINE , MOON ANNE , HWANG TAE-HO , LEE YU KYOUNG , KIM MI-KYUNG , SILLAJEN INC
发明人： KIRN DAVID , BELL JOHN , BREITBACH CAROLINE , MOON ANNE , HWANG TAE-HO , LEE YU KYOUNG , KIM MI-KYUNG
IPC分类号： A61K39/12
CPC分类号： A61K39/285 , A61K35/26 , A61K35/76 , A61K35/761 , A61K35/763 , A61K35/768 , A61K39/0011 , A61K39/12 , A61K39/125 , A61K39/145 , A61K39/165 , A61K39/17 , A61K39/205 , A61K39/235 , A61K39/245 , A61K39/395 , A61K45/06 , A61K2039/505 , A61K2039/507 , A61K2039/55522 , C07K16/18 , C07K16/30 , C07K2317/14 , C07K2317/734 , C12N7/00 , C12N2710/10034 , C12N2710/16632 , C12N2710/16634 , C12N2710/24034 , C12N2710/24132 , C12N2720/12232 , C12N2750/14034 , C12N2760/16034 , C12N2760/18134 , C12N2760/18434 , C12N2760/18734 , C12N2760/20034 , C12N2760/20232 , C12N2770/32034 , C12N2770/32334 , C12N2770/36034 , G01N33/574
摘要： The present invention relates to methods and compositions for use in inducing tumor-specific antibody mediated complement-dependent cytotoxic response in an animal having a tumor comprising administering to said animal a composition comprising a replication competent oncolytic virus wherein administration of the composition induces in the animal production of antibodies that mediate a CDC response specific to said tumor.
摘要翻译：本发明涉及用于在具有肿瘤的动物中诱导肿瘤特异性抗体介导的补体依赖性细胞毒性应答的方法和组合物，所述方法和组合物包括向所述动物施用包含可复制的溶瘤病毒的组合物，其中组合物在动物中的诱导产生介导对所述肿瘤特异性的CDC反应的抗体。

10. 发明申请

WO2011118976A3 PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND THE METHOD FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE USING THE SAME 审中-公开
标题翻译：用于预防或治疗非酒精性脂肪肝疾病的药物组合物及使用该方法预防或治疗非酒精性脂肪肝病
公开(公告)号：WO2011118976A3
公开(公告)日：2012-03-15
申请号：PCT/KR2011001988
申请日：2011-03-23
申请人： DONG A PHARM CO LTD , AN GOOK-JUN , YANG EUN-KYOUNG , CHO EUN-JUNG , CHAE YU-NA , CHOI SONG-HYEN , KIM HA-DONG , SHIN CHANG-YELL , KIM MI-KYUNG , KWAK WOO-YOUNG , KIM HEUNG-JAE , SON MOON-HO , KIM SOON-HOE
发明人： AN GOOK-JUN , YANG EUN-KYOUNG , CHO EUN-JUNG , CHAE YU-NA , CHOI SONG-HYEN , KIM HA-DONG , SHIN CHANG-YELL , KIM MI-KYUNG , KWAK WOO-YOUNG , KIM HEUNG-JAE , SON MOON-HO , KIM SOON-HOE
IPC分类号： A61K31/496 , A61K31/401 , A61P1/00 , A61P1/16
CPC分类号： A61K31/495 , A61K31/4985
摘要： The present invention provides a pharmaceutical composition for the prevention and treatment of a non-alcoholic fatty liver disease (NAFLD), containing an active ingredient selected from the group consisting of Compound 1 represented by formula 1, sitagliptin, vildagliptin, linagliptin or a pharmaceutically acceptable salt thereof. Further, the present invention provides a method for the prevention or treatment of a non-alcoholic fatty liver disease, including administering an effective amount of an active ingredient selected from the group consisting of Compound 1 represented by formula 1, sitagliptin, vildagliptin, linagliptin or a pharmaceutically acceptable salt thereof to a mammal including a human in need thereof. Further, the present invention provides use of Compound 1 represented by formula 1, sitagliptin, vildagliptin, linagliptin or a pharmaceutically acceptable salt thereof, for manufacturing a pharmaceutical composition for the prevention or treatment of a non-alcoholic fatty liver disease.
摘要翻译：本发明提供了一种用于预防和治疗非酒精性脂肪肝疾病（NAFLD）的药物组合物，其含有选自由式1表示的化合物1，西格列汀，维格列汀，利格列汀或其药学上可接受的组的盐。此外，本发明提供了一种预防或治疗非酒精性脂肪性肝病的方法，包括给予有效量的选自由式1表示的化合物1，西格列汀，维格列汀，利格列汀或其药学上可接受的盐包括需要其的人的哺乳动物。此外，本发明提供了用于制备用于预防或治疗非酒精性脂肪肝疾病的药物组合物的式1化合物1，西他列汀，维格列汀，利格列汀或其药学上可接受的盐的用途。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式